Cipla
平静Indian pharmaceutical company with global generics and respiratory portfolio
公司概况
行业
同行对比
信号时间线
2 条日期未知
监管与政策官方—
Cipla recalls over 400 cartons of cancer drug in US: FDA
Cipla is recalling over 400 cartons of Nilotinib Capsules in the US due to a manufacturing defect.
产品发布官方—
Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy
Cipla has launched a generic version of Saxenda® (Liraglutide Injection) in the US for weight management therapy.
订阅 Cipla 信号简报
当该公司有新信号时，立即收到通知。